Terazosin - CISMeF

Preferred Label : Terazosin;

Alternative definition : NCI-GLOSS: A drug used to treat urinary problems caused by an enlarged prostate. It is also used to treat high blood pressure and is being studied in the treatment of other conditions. Terazosin relaxes muscle tissue in blood vessels and in the prostate. It is a type of alpha blocker.;

UNII : 8L5014XET7;

InChIKey : VCKUSRYTPJJLNI-UHFFFAOYSA-N;

CAS number : 63590-64-7;

Chemical formula : C19H25N5O4;

ChEBI ID : CHEBI:9445;

Codes from synonyms : CDR0000543114; 31751;

Détails

Origin ID

C61964;

UMLS CUI

C0076107;

Currated CISMeF NLP mapping
- Terazosin [LOINC component]
- Terazosin [ICD-11 Extension code]
- Terazosin [ICHI extension code]
- Terazosin [SMS substance]
- Terazosin [MeSH concept]
- Terazosin [MeSH Supplementary Concept]
- Terazosin (substance) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing terazosin (medicinal product) [SNOMED CT concept]
- Terazosin [LOINC component]
- Terazosin [ICD-11 Extension code]
- Terazosin [MeSH concept]
- Terazosin [MeSH Supplementary Concept]
- Terazosin (substance) [SNOMED CT concept]
- terazosin [ATC Code]
Validated automatic mappings to BTNT
- terazosin [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Terazosin Hydrochloride [NCIt concept]
- Terazosin Hydrochloride Anhydrous [NCIt concept]
is_free_acid_or_base_form_of
- Terazosin Hydrochloride [NCIt concept]
- Terazosin Hydrochloride Anhydrous [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients